Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

HEL/NXTMH stock hub

HEL/NXTMH has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HEL/NXTMHis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

68M

Nasdaq Helsinki

Market data

Price

Recent price action with selectable time range.

HEL/NXTMHHEL/NXTMH

—

Loading chart…

In the news

Latest news · HEL/NXTMH

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E67.1

P25 n/aP50 n/aP75 n/a

Trailing P/E156.7

P25 n/aP50 n/aP75 n/a

ROE14.5

P25 n/aP50 n/aP75 n/a

ROIC11.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HEL/NXTMH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

204

Groups with data

Currency

EUR

Showing 204 of 204 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Finland
Country code	FI
Employees	40
Employees Change	3%
Employees Change Percent	8.11
Enterprise value	EUR 69.5M
Exchange	Nasdaq Helsinki
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Devices
Isin	FI4000506811
Last refreshed	2026-05-10
Market cap	EUR 68M
Price	EUR 9.4
Price currency	EUR
Rev Per Employee	310,326.38x
Sector	Healthcare
Sic	3845
Symbol	hel/NXTMH
Website	https://www.nexstim.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.84%
EV Earnings	121.18x
EV/EBIT	100.33x
EV/EBITDA	74.93x
EV/FCF	-1,859.68x
EV/Sales	5.6x
FCF yield	-0.05%
Forward P/E	67.14x
P/B ratio	16.26x
P/E ratio	156.67x
P/S ratio	5.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5.13%
EBITDA Margin	7.02%
Gross margin	79.78%
Gross Profit	EUR 9.9M
Gross Profit Growth	4.28%
Gross Profit Growth Q	8.13%
Gross Profit Growth3 Y	8.75%
Gross Profit Growth5 Y	13.11%
Net Income	EUR 573,201
Net Income Growth Q	1,533.97%
Net Income Growth Quarters	2%
Net Income Growth Years	2%
Pretax Margin	4.65%
Profit Margin	4.62%
Profit Per Employee	EUR 14,330
Profitable Years	1
ROA	2.91
Roa5y	-2.65
ROCE	8.74
ROE	14.54
Roe5y	-22.25
ROIC	11.21
Roic5y	-27.21

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-21.7%
Cagr1y	22.1%
Cagr3y	35.83%
Cagr5y	9.76%
EPS Growth Q	821.7
EPS Growth Quarters	2
EPS Growth Years	2
FCF Growth Q	35.25%
OCF Growth	-11.44%
OCF Growth Q	14.37%
Revenue Growth	21.54x
Revenue Growth Q	12.51x
Revenue Growth Quarters	5x
Revenue Growth Years	2x
Revenue Growth3 Y	9.85x
Revenue Growth5 Y	13.99x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.91
Assets	EUR 13.2M
Cash	EUR 2.7M
Current Assets	EUR 7.5M
Current Liabilities	EUR 5.9M
Debt	EUR 4.1M
Debt EBITDA	EUR 4.74
Debt Equity	EUR 0.99
Debt FCF	EUR -111
Equity	EUR 4.2M
Liabilities	EUR 9M
Long Term Assets	EUR 5.7M
Long Term Liabilities	EUR 3.1M
Net Cash	EUR -1.5M
Net Cash By Market Cap	EUR -2.14
Net Debt EBITDA	EUR 1.67
Net Debt Equity	EUR 0.35
Tangible Book Value	EUR 3.9M
Tangible Book Value Per Share	EUR 0.54
WACC	6.32

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.27
Inventory Turnover	3.48
Net Working Capital	EUR 479,366
Quick ratio	1.1
Working Capital	EUR 1.6M
Working Capital Turnover	EUR 5.07

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-39.19%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-91.33%
1Y total return	22.08%
200-day SMA	12.54
3Y total return	150.67%
50-day SMA	9.14
50-day SMA vs 200-day SMA	50under200
5Y total return	59.32%
All Time High	23,100
All Time High Change	-99.96%
All Time High Date	2015-12-03
All Time Low	1.52
All Time Low Change	518.42%
All Time Low Date	2020-05-14
ATR	0.41
Beta	0.45
Beta1y	0.52
Beta2y	0.29
Ch YTD	-33.8
High	9.68
High52	16.45
High52 Date	2025-10-16
High52ch	-42.86%
Low	9
Low52	7.4
Low52 Date	2025-05-16
Low52ch	27.03%
Ma50ch	2.89%
Price vs 200-day SMA	-25.02%
RSI	55.64
RSI Monthly	43.03
RSI Weekly	35.36
Sharpe ratio	0.54x
Sortino ratio	0.9
Total Return	-39.19%
Tr YTD	-33.8
Tr1m	3.98%
Tr1w	7.18%
Tr3m	-25.98%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 636,470
Operating Income Growth	97.56
Operating Income Growth Q	168.6
Operating margin	5.13

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,214,149%
Net Borrowing	-1,231,300
Shares Insiders	16.75%
Shares Institutions	2.35%
Shares Out	7,234,896
Shares Qo Q	81.98%
Shares Yo Y	39.19%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -37,352
Average Volume	4,140.2x
Bv Per Share	0.58
CAPEX	EUR -1.7M
Ch10y	-99.72
Ch1m	3.98
Ch1w	7.18
Ch1y	22.08
Ch3m	-25.98
Ch3y	150.7
Ch5y	59.32
Ch6m	-37.12
Change	2.06%
Change From Open	2.06
Close	9.21
Days Gap	0
Depreciation Amortization	234,651
Dollar Volume	32,016.4
Earnings Date	2026-08-14
EBIT	EUR 636,470
EBITDA	EUR 871,121
EPS	EUR 0.06
F Score	6
FCF	EUR -37,352
FCF EV Yield	-0.05x
FCF Per Share	EUR -0.01
Financing CF	-1,076,986
Fiscal Year End	December
Founded	2,000
Graham Number	0.88469
Graham Upside	-90.59
Income Tax	EUR 4,379
Investing CF	-1,689,861
Is Primary Listing	1
Last Earnings Date	2026-02-26
Last Report Date	2025-12-31
Last Split Date	2021-05-17
Last Split Type	Reverse
Ma150	12.21
Ma150ch	-22.99%
Ma20	9.01
Ma20ch	4.36%
Net CF	-1,187,594
Next Earnings Date	2026-08-14
Open	9.21
P OCF Ratio	40.83
Position In Range	58.82
Ppne	363,291
Price Date	2026-05-08
Price EBITDA	EUR 78.07
Ptbv Ratio	17.45
Relative Volume	0.83x
Revenue	12,413,055x
Tax By Revenue	0.04x
Tax Rate	0.76%
Tr6m	-37.12%
Volume	3,406
Z Score	1.07

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HEL/NXTMH pay a dividend?

Capital-return profile for this ticker.

Performance

HEL/NXTMH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HEL/NXTMH?

Insider, institutional, and short-interest positioning.

Institutional ownership

+2.4%

Share of float held by funds and institutions

Insider ownership

+16.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+39.2%

Negative means the company is buying back shares.

Technical

HEL/NXTMH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

55.6

Neutral momentum band

Price vs 200-day MA

-25.0%

50/200-day relationship not available

Beta (5Y)

0.45

Less volatile than the market

Sharpe ratio

0.54

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HEL/NXTMH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hel/NXTMH stock rating?

hel/NXTMH is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hel/NXTMH analysis?

The full report lives at /stocks/hel/NXTMH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hel/NXTMH?

The latest report frames hel/NXTMH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hel/NXTMH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.